0001209191-22-009337.txt : 20220214
0001209191-22-009337.hdr.sgml : 20220214
20220214164729
ACCESSION NUMBER: 0001209191-22-009337
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220211
FILED AS OF DATE: 20220214
DATE AS OF CHANGE: 20220214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coleman Glenn
CENTRAL INDEX KEY: 0001434369
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26224
FILM NUMBER: 22633699
MAIL ADDRESS:
STREET 1: C/O CURTISS-WRIGHT CORPORATION
STREET 2: 4 BECKER FARM ROAD
CITY: ROSELAND
STATE: NJ
ZIP: 07068
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEGRA LIFESCIENCES HOLDINGS CORP
CENTRAL INDEX KEY: 0000917520
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 510317849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1100 CAMPUS ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 6092750500
MAIL ADDRESS:
STREET 1: 1100 CAMPUS ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: INTEGRA LIFESCIENCES CORP
DATE OF NAME CHANGE: 19950614
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-11
0
0000917520
INTEGRA LIFESCIENCES HOLDINGS CORP
IART
0001434369
Coleman Glenn
1100 CAMPUS ROAD
PRINCETON
NJ
08540
0
1
0
0
Executive Vice President & COO
Common Stock
2022-02-11
4
A
0
5892
0.00
A
34046
D
Common Stock
2022-02-11
4
A
0
10837
0.00
A
44883
D
Common Stock
2022-02-11
4
A
0
12576
0.00
A
57459
D
On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2019 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 34% of the shares will vest on March 13, 2022 at 150% of target, the third anniversary of the grant date.
Includes 373 shares acquired under the Integra Employee Stock Purchase Plan since the date of the reporting person's most recent filing on Form 4.
On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 13, 2020 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2022 at 150% of target, the second anniversary of the grant date.
On February 11, 2022, the Compensation Committee certified that the Company achieved it's performance goal for fiscal year 2021 under the March 12, 2021 performance stock award at or above the threshold level based on a annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 12, 2022 at 200% of target, the first anniversary of the grant date.
/s/ Eric Schwartz; Attorney-in-Fact
2022-02-14